Trait
SNPs associated with Drug Use Measurement, Benign Prostatic Hyperplasia
6 genetic variants across 2 genes have been associated with Drug Use Measurement, Benign Prostatic Hyperplasia in published research. Key genes include LOC105378523, SCGB1C1.
Associated variants6 total
| rsid | Gene | Effect | Evidence |
|---|---|---|---|
| rs10886894 | LOC105378523 | GWAS association (p=1.0e-17) | Major Consortium Study |
| rs6482195 | — | GWAS association (p=8.0e-16) | Major Consortium Study |
| rs677394 | — | GWAS association (p=3.0e-11) | Major Consortium Study |
| rs465498 | — | GWAS association (p=4.0e-22) | Major Consortium Study |
| rs7124615 | SCGB1C1 | GWAS association (p=2.0e-17) | Major Consortium Study |
| rs11084596 | — | GWAS association (p=4.0e-21) | Major Consortium Study |
Associations aggregated from the GWAS Catalog and curated literature. Informational only — not medical advice.